California, other states join FTC bid to block Amgen deal

Horizon Therapeutics

22/06/2023 21:38

June 22 (Reuters) - The states of California, Minnesota
and Wisconsin on Thursday joined a Federal Trade Commission
lawsuit to stop Amgen's  AMGN.O  $27.8 billion deal to buy
Horizon Therapeutics, according to a court filing.
    The FTC said last month it filing suit opposing the deal
because it would give Amgen "monopoly positions" for medicines
used to treat thyroid eye disease and chronic refractory gout.
California Attorney General Rob Bonta said "Amgen’s proposed
acquisition of Horizon is dangerous for the future of medicine,
dangerous for innovation and research, and most importantly,
dangerous for sick people in need of often lifesaving drugs."

 (Reporting by David Shepardson)
 ((David.Shepardson@thomsonreuters.com; 2028988324;))